Scholars Central

Research articlePublished 2017

Use of an Amphoteric Solution in Eye, Skin and Oral Chemical Exposures: Retrospective Multicenter Clinical Case Series

Authors: Fortin JL, Fontaine M, Bodson L, Depil-Duvala A, Bitar MP, Macher JM, Paulin P, Ravat F, Hall AH

Journal of Clinical Toxicology

Volume 7 · Issue 2 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: A polyvalent amphoteric flushing solution (Diphoterine®) has been in use for a number of years, mainly in industrial settings for decontamination of acid, base, and other corrosive or irritant substances eye and skin splashes. Methods: Retrospective collection of 34 cases from several centers reporting use of Diphoterine® decontamination of eye, skin or oral chemical exposures. The following data were retrieved: exposure circumstances (workplace, domestic, deliberate assault), chemical nature and pH, exposure type, initial clinical signs, clinical signs after flushing, initial and final visual analog scale (VAS) pain ratings, consulting specialist physicians’ conclusions. Results: 58.8% of the 34 cases were occupational exposures, 29.4% were domestic, 5.9% occurred in schools, and 5.9% were deliberate chemical assaults. Of involved chemicals, 11 were basic substances, 11 were acidic, 1 was an oxidizing substance, 2 were solvents, and 9 were miscellaneous substances. There were 21 ocular exposures, 8 cutaneous exposures, 4 mixed (ocular/cutaneous), and 1 oral exposure. Initial clinical findings in ocular exposures were: pain, blepharospasm, hyperemia, palpebral edema, excessive tearing, and blurred vision. Of cutaneous exposures, 1 was a deep necrotic injury and 7 were superficial. Median (IQR) VAS before flushing with Diphoterine® was 7; VAS after ocular or skin flushing was 1. Conclusion: Early application of the amphoteric solution to the eye or skin reduces the intensity of pain associated with chemical injury. While randomized clinical trials are lacking, early use of the amphoteric solution appears to reduce the incidence of sequelae.

Subjects

Toxicology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Toxicology
  • SubjectToxicology
  • BylineArticles whose byline prints “Fortin JL”
  • BylineArticles whose byline prints “Fontaine M”
  • BylineArticles whose byline prints “Bodson L”
  • BylineArticles whose byline prints “Depil-Duvala A”
  • BylineArticles whose byline prints “Bitar MP”
  • BylineArticles whose byline prints “Macher JM”
  • BylineArticles whose byline prints “Paulin P”
  • BylineArticles whose byline prints “Ravat F”